Recursion Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Recursion Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Recursion Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Recursion Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $12M | 1.2M | 9.86 |
| 2023-09-30 | $5.1M | 665k | 7.65 |
| 2023-06-30 | $4.3M | 577k | 7.47 |
| 2023-03-31 | $3.6M | 535k | 6.67 |
| 2022-12-31 | $4.5M | 583k | 7.71 |
| 2022-06-30 | $1.6M | 196k | 8.14 |
| 2022-03-31 | $1.5M | 209k | 7.16 |
| 2021-12-31 | $2.1M | 124k | 17.13 |
| 2021-09-30 | $429k | 19k | 22.97 |